Page 129 - SRL Diagnostics

A TO F

9222RFX - BONE MARROW REFLEX TO LAP
BY MICROSCOPY + CYTOCHEMISTRY SPECIAL STAINS
SPECIMEN: BONE MARROW SMEAR + PERIPHERIAL  A
SMEAR + CLINICAL HISTORY, 5-6 BM SMEARS + 2 PB
SMEARS, CBC
À REPORTED ON: 6TH DAY OF
ACCEPTANCE CUT OFF: DAILY: 12:00 HRS RUN
RUN DAY: DAILY: 12:00 HRS

RD1317 - BRAF V600E MUTATION
BY ARMS PCR
SPECIMEN: TISSUE (NORMAL SALINE) / PARAFFIN  A
BLOCK+CLINICAL HISTORY, 0.5 CM X 0.5 CM X 0.5 CM
ACCEPTANCE CUT OFF: SAT, TUES: 16:00 HRS À REPORTED ON: 5TH DAY OF
RUN DAY: MON, THURS 09:30 HRS RUN

RD1421 - BRCA NEXT (BRCA 1 & 2 GENETIC TEST) - BREAST CANCER
BY NEXT GENERATION SEQUENCING
SPECIMEN: EDTA WHOLE BLOOD + CLINICAL HISTORY,  A
6 ML ( 4 ML)
ACCEPTANCE CUT OFF: SAT: 15:00 HRS À REPORTED ON: 21ST DAY OF
RUN DAY: MON: 09:30 HRS RUN

1692 - BREAST CANCER PANEL (ER,PGR, HER 2/NEU, KI-67)
BY IMMUNOHISTOCHEMISTRY
SPECIMEN TISSUE IN 10% FORMALINE FOR 24-48  R/F
HOURS/PARAFFIN BLOCK + SITE OF BIOPSY & CLINICAL
DETAILS MANDATORY. IF TISSUE RECEIVED IT WILL BE
CHARGED EXTRA. TIME AND DURATION OF FIXATIVE À REPORTED ON: 5TH OF RUN
SHOULD BE MENTIONED ON TRF. 1CM/1 BLOCK
ACCEPTANCE CUT OFF: DAILY: 11:00 HRS
RUN DAY: DAILY: 11:00 HRS

3022 - BREAST CANCER MONITOR I (CA 15-3, CEA)
BY CHEMILUMINESCENCE
SPECIMEN: SERUM ( AGE + SEX + CLINICAL HISTORY  R/F
REQUIRED ), 2 ML
ACCEPTANCE CUT OFF: SUN, TUE, THURS: 16:30 HRS À REPORTED ON: SAME DAY OF
RUN DAY: SUN, TUE, THURS: 16:30 HRS RUN

123